STAT

Opinion: The physician of the future: a precisionist who sees patients as they are

Drug development and evidence-based medicine are aimed at the average patient. But we are all different.

“We see this sometimes” is a phrase doctors use now and then to “reassure” patients. I find it disturbing and paternalistic and hope it is soon purged from our vocabulary, made archaic by precision medicine.

I first heard the phrase in 1986 as a medical student on rounds at Duke University School of Medicine. The rounding team included an attending physician — an internationally prominent neurologist — along with a second-year neurology resident, an internal medicine intern, a pharmacist, and a physician assistant student. As was the culture of the time, we moved from patient to patient and stood around the bedside while the medical student presented the case to the attending physician, who then led a discussion

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A J&J Cough Syrup, A Pfizer And Moderna Patent Suit, And More
A Johnson & Johnson children’s cough syrup found to contain unsafe levels of a toxic industrial solvent was sold in six African countries.

Related Books & Audiobooks